{"database": "lobbying", "table": "lobbying_activities", "rows": [[2186753, "56db97d3-cddb-4921-946b-6c43e79a2049", "Q3", "TRAVERE THERAPEUTICS", 401104190, "TRAVERE THERAPEUTICS", 2018, "third_quarter", "PHA", "Orphan Drug Act, Drug Quality and Security Act drug safety issues, drug pricing, opioid legislation provisions related to opioid sparing, FAST Generics and CREATES Acts, FDA issues", "HOUSE OF REPRESENTATIVES,SENATE", null, 220000, 0, 0, "2018-10-16T22:45:04.840000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2186753"], "units": {}, "query_ms": 33.81098702084273, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}